Roderick Wong于2026年10月5日通过场外股本衍生工具交易增持再鼎医药（09688）ADS对应的普通股1070.51万股（每股ADS代表10股普通股），均价24.87美元，涉资约2.66亿美元。该笔交易属场外衍生品交易，并非在二级市场直接买卖正股。
Roderick Wong此次增持前持有再鼎医药好仓1.04亿股，占比9.1%；增持后持股量为1.14亿股，好仓比例升至10.04%。
Roderick Wong于2026年10月5日通过场外股本衍生工具交易增持再鼎医药（09688）ADS对应的普通股1070.51万股（每股ADS代表10股普通股），均价24.87美元，涉资约2.66亿美元。该笔交易属场外衍生品交易，并非在二级市场直接买卖正股。
Roderick Wong此次增持前持有再鼎医药好仓1.04亿股，占比9.1%；增持后持股量为1.14亿股，好仓比例升至10.04%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.